4 results on '"Junya Miyahara"'
Search Results
2. Correction to: Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
- Author
-
Junya Higuchi, Kentaro Takagi, Junya Miyahara, Ryota Yamagami, Shinsaku Tsuji, Shuji Taketomi, Satoshi Miwa, Ryota Chijimatsu, Kohei Kawaguchi, Hisatoshi Ishikura, Naohiro Tachibana, Yuji Maenohara, Gensuke Okamura, Hiroshi Inui, Shin Sameshima, Keiu Nakazato, Sakae Tanaka, and Taku Saito
- Subjects
Medicine (General) ,Medicine (miscellaneous) ,Adipose tissue ,QD415-436 ,Biology ,Biochemistry ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Mice ,R5-920 ,In vivo ,Animals ,Humans ,Divergence (statistics) ,Cells, Cultured ,Stem Cells ,Correction ,Cell Differentiation ,Cell Biology ,Chondrogenesis ,In vitro ,Cell biology ,Cartilage ,Adipose Tissue ,Molecular Medicine ,Stem cell - Abstract
Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondrogenesis in vitro and in vivo remains undefined. The purpose of this study was to investigate the intrinsic chondrogenic condition depends on cell types and explore an indicator to select useful stem cells for cartilage regeneration.The chondrogenic potential of two different stem cell types derived from adipose tissue (ASCs) and synovium (SSCs) of mice and humans was assessed using bone morphogenic protein-2 (BMP2) and transforming growth factor-β1 (TGFβ1). Their in vivo chondrogenic potential was validated through transplantation into a mouse osteochondral defect model.All cell types showed apparent chondrogenesis under the combination of BMP2 and TGFβ1 in vitro, as assessed by the formation of proteoglycan- and type 2 collagen (COL2)-rich tissues. However, our results vastly differed with those observed following single stimulation among species and cell types; apparent chondrogenesis of mouse SSCs was observed with supplementation of BMP2 or TGFβ1, whereas chondrogenesis of mouse ASCs and human SSCs was observed with supplementation of BMP2 not TGFβ1. Human ASCs showed no obvious chondrogenesis following single stimulation. Mouse SSCs showed the formation of hyaline-like cartilage which had less fibrous components (COL1/3) with supplementation of TGFβ1. However, human cells developed COL1/3+ tissues with all treatments. Transcriptomic analysis for TGFβ receptors and ligands of cells prior to chondrogenic induction did not indicate their distinct reactivity to the TGFβ1 or BMP2. In the transplanted site in vivo, mouse SSCs formed hyaline-like cartilage (proteoglycan+/COL2+/COL1-/COL3-) but other cell types mainly formed COL1/3-positive fibrous tissues in line with in vitro reactivity to TGFβ1.Optimal chondrogenic factors driving chondrogenesis from somatic stem cells are intrinsically distinct among cell types and species. Among them, the response to TGFβ1 may possibly represent the fate of stem cells when locally transplanted into cartilage defects.
- Published
- 2021
3. Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
- Author
-
Yuji Maenohara, Gensuke Okamura, Hiroshi Inui, Kentaro Takagi, Ryota Chijimatsu, Keiu Nakazato, Junya Miyahara, Sakae Tanaka, Hisatoshi Ishikura, Shinsaku Tsuji, Junya Higuchi, Kohei Kawaguchi, Naohiro Tachibana, Ryota Yamagami, Satoshi Miwa, Taku Saito, Shin Sameshima, and Shuji Taketomi
- Subjects
0301 basic medicine ,Cell type ,Medicine (General) ,Medicine (miscellaneous) ,Adipose tissue ,QD415-436 ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,R5-920 ,medicine ,Synovial stem cells ,Chemistry ,Regeneration (biology) ,Cartilage ,Research ,Stem cell transplantation ,Cell Biology ,Somatic stem cells ,Chondrogenesis ,Adipose stem cells ,Cell biology ,Transplantation ,030104 developmental biology ,medicine.anatomical_structure ,Transforming growth factor β (TGF-β) ,030220 oncology & carcinogenesis ,Molecular Medicine ,Stem cell ,Adult stem cell - Abstract
Background Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondrogenesis in vitro and in vivo remains undefined. The purpose of this study was to investigate the intrinsic chondrogenic condition depends on cell types and explore an indicator to select useful stem cells for cartilage regeneration. Methods The chondrogenic potential of two different stem cell types derived from adipose tissue (ASCs) and synovium (SSCs) of mice and humans was assessed using bone morphogenic protein-2 (BMP2) and transforming growth factor-β1 (TGFβ1). Their in vivo chondrogenic potential was validated through transplantation into a mouse osteochondral defect model. Results All cell types showed apparent chondrogenesis under the combination of BMP2 and TGFβ1 in vitro, as assessed by the formation of proteoglycan- and type 2 collagen (COL2)-rich tissues. However, our results vastly differed with those observed following single stimulation among species and cell types; apparent chondrogenesis of mouse SSCs was observed with supplementation of BMP2 or TGFβ1, whereas chondrogenesis of mouse ASCs and human SSCs was observed with supplementation of BMP2 not TGFβ1. Human ASCs showed no obvious chondrogenesis following single stimulation. Mouse SSCs showed the formation of hyaline-like cartilage which had less fibrous components (COL1/3) with supplementation of TGFβ1. However, human cells developed COL1/3+ tissues with all treatments. Transcriptomic analysis for TGFβ receptors and ligands of cells prior to chondrogenic induction did not indicate their distinct reactivity to the TGFβ1 or BMP2. In the transplanted site in vivo, mouse SSCs formed hyaline-like cartilage (proteoglycan+/COL2+/COL1−/COL3−) but other cell types mainly formed COL1/3-positive fibrous tissues in line with in vitro reactivity to TGFβ1. Conclusion Optimal chondrogenic factors driving chondrogenesis from somatic stem cells are intrinsically distinct among cell types and species. Among them, the response to TGFβ1 may possibly represent the fate of stem cells when locally transplanted into cartilage defects.
- Published
- 2021
4. Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human.
- Author
-
Ryota, Chijimatsu, Satoshi, Miwa, Gensuke, Okamura, Junya, Miyahara, Naohiro, Tachibana, Hisatoshi, Ishikura, Junya, Higuchi, Yuji, Maenohara, Shinsaku, Tsuji, Shin, Sameshima, Kentaro, Takagi, Keiu, Nakazato, Kohei, Kawaguchi, Ryota, Yamagami, Hiroshi, Inui, Shuji, Taketomi, Tanaka, Sakae, and Saito, Taku
- Subjects
ENDOCHONDRAL ossification ,CARTILAGE regeneration ,CARTILAGE cells ,STEM cell transplantation ,ADIPOSE tissues ,SOMATIC cells - Abstract
Background: Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondrogenesis in vitro and in vivo remains undefined. The purpose of this study was to investigate the intrinsic chondrogenic condition depends on cell types and explore an indicator to select useful stem cells for cartilage regeneration. Methods: The chondrogenic potential of two different stem cell types derived from adipose tissue (ASCs) and synovium (SSCs) of mice and humans was assessed using bone morphogenic protein-2 (BMP2) and transforming growth factor-β1 (TGFβ1). Their in vivo chondrogenic potential was validated through transplantation into a mouse osteochondral defect model. Results: All cell types showed apparent chondrogenesis under the combination of BMP2 and TGFβ1 in vitro, as assessed by the formation of proteoglycan- and type 2 collagen (COL2)-rich tissues. However, our results vastly differed with those observed following single stimulation among species and cell types; apparent chondrogenesis of mouse SSCs was observed with supplementation of BMP2 or TGFβ1, whereas chondrogenesis of mouse ASCs and human SSCs was observed with supplementation of BMP2 not TGFβ1. Human ASCs showed no obvious chondrogenesis following single stimulation. Mouse SSCs showed the formation of hyaline-like cartilage which had less fibrous components (COL1/3) with supplementation of TGFβ1. However, human cells developed COL1/3+ tissues with all treatments. Transcriptomic analysis for TGFβ receptors and ligands of cells prior to chondrogenic induction did not indicate their distinct reactivity to the TGFβ1 or BMP2. In the transplanted site in vivo, mouse SSCs formed hyaline-like cartilage (proteoglycan+/COL2+/COL1−/COL3−) but other cell types mainly formed COL1/3-positive fibrous tissues in line with in vitro reactivity to TGFβ1. Conclusion: Optimal chondrogenic factors driving chondrogenesis from somatic stem cells are intrinsically distinct among cell types and species. Among them, the response to TGFβ1 may possibly represent the fate of stem cells when locally transplanted into cartilage defects. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.